Dr Reddys Laboratories Share Price Today - Live Blog for July 21, 2025

Dr Reddys Laboratories Ltd share price surged by 0.07%. With its current market price standing at ₹1,260.15 per share, this stock is garnering increased attention from the investment community.

Dr Reddys Laboratories Ltd experienced a substantial 0.07% boost in its share price and has garnered significant attention from the market. It's now trading at ₹1,260.15, making it an appealing option for investors.

With a -0.01% decrease, Dr Reddys Laboratories Ltd's share price is now ₹1,257.55. Investors should examine the factors driving this decline. The stock's PE ratio is 18.5700, whereas the industry PE ratio stands at 35.9113.

The share price of Dr Reddys Laboratories Ltd soared by an impressive 0.03%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹1,257.70 per share.

Dr Reddys Laboratories Ltd observed a -0.12% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,257.90. The stock has a PE ratio of 18.5700, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

After a significant 0.14% gain, Dr Reddys Laboratories Ltd's shares are now valued at ₹1,259.05 in the current market. This upward movement is attracting attention from both retail and institutional investors.

The share price of Dr Reddys Laboratories Ltd plunged by -0.11%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,257.15, but investors are assessing whether this is a temporary dip or a long-term trend.

Dr Reddys Laboratories Ltd's stock has surged by 0.10%, and it is currently trading at ₹1,258.30. Additionally, the stock maintains a PE ratio of 18.5700, while the industry PE is 35.9113.

Dr Reddys Laboratories Ltd's share price rallied by 0.09%, reaching the current market price of ₹1,257.05. This surge is indicative of the stock's recent positive performance.

Dr Reddys Laboratories Ltd experienced a substantial 0.02% boost in its share price and has garnered significant attention from the market. It's now trading at ₹1,255.20, making it an appealing option for investors.

In the financial arena, Dr Reddys Laboratories Ltd's stock price has increased by 0.03%, with its current market value per share resting at ₹1,255.00. This development highlights the stock's appeal to investors.

Dr Reddys Laboratories Ltd witnessed a -0.04% decrease in its share price, and it is currently trading at ₹1,256.55. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 18.5700, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd shares saw a -0.04% decrease, reaching a current market price of ₹1,256.55. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 18.5700, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd stock price decreased by -0.04%, with the current market value at ₹1,256.55 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

Dr Reddys Laboratories Ltd's stock has risen by a substantial 0.11%, and as of now, it's trading at ₹1,257.35 per share. This upward trajectory is attracting keen interest from investors.

Dr Reddys Laboratories Ltd's shares saw an increase of 0.26%, reaching the current market price of ₹1,256.00. This development underscores the stock's growing popularity.

Dr Reddys Laboratories Ltd's stock has surged by 0.14%, and it is currently trading at ₹1,252.80. Additionally, the stock maintains a PE ratio of 18.5700, while the industry PE is 35.9113.

Dr Reddys Laboratories Ltd experienced a -0.06% dip in its share price and is currently trading at ₹1,251.00. The stock has a PE ratio of 18.5700, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

The share price of Dr Reddys Laboratories Ltd experienced an uptrend, surging by 0.04% recently. As of now, this stock is actively trading at a current market price of ₹1,253.35 per share, attracting attention from investors.

Demonstrating a commendable 0.04% gain, Dr Reddys Laboratories Ltd's share price is currently situated at ₹1,253.35. In terms of valuation, the stock maintains a PE ratio of 18.5700, while the industry PE ratio stands at 35.9113.

Dr Reddys Laboratories Ltd share price has declined by -0.32%, and it's currently trading at ₹1,251.20. The stock maintains a PE of 18.5700, while the industry PE is 35.9113, prompting discussions about its valuation.

Demonstrating a commendable 0.12% gain, Dr Reddys Laboratories Ltd's share price is currently situated at ₹1,256.15. In terms of valuation, the stock maintains a PE ratio of 18.5700, while the industry PE ratio stands at 35.9113.

Dr Reddys Laboratories Ltd's share price has experienced a notable 0.24% upswing, and it's currently trading at ₹1,254.60 per share. Investors are closely watching this development.

The stock of Dr Reddys Laboratories Ltd is on the rise, registering an impressive 0.38% increase and currently trading at ₹1,251.95 per share. Investors are taking notice of this upward momentum.

The share price of Dr Reddys Laboratories Ltd experienced an impressive 0.38% upswing and is currently trading at ₹1,251.95, indicating strong market sentiment.

Dr Reddys Laboratories Ltd experienced a -0.29% downturn in its share price, and it's currently trading at ₹1,247.65. This situation is generating interest among value investors who are evaluating the stock's potential.

Dr Reddys Laboratories Ltd shares saw a decrease of -0.20%, reaching a current market price of ₹1,251.45. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.